You are here

Esbriet

InterMune Sale Looms as Lung Drug Nears FDA Nod: Real M&A

Bloomberg

Wed, 02/20/13 - 12:13 pm

Rejection of InterMune’s Drug Told Early to FDA Advisers

Bloomberg

Wed, 12/26/12 - 09:23 am

Esbriet Sales Demonstrating Growth; Expansion into New Markets Continues

Yahoo/Reuters

Fri, 11/9/12 - 11:21 am

Why InterMune Shares Plunged

Motley Fool

Mon, 04/9/12 - 12:14 pm

Drug Pricing Takes This Biotech on a Rollercoaster

Motley Fool

Sat, 03/17/12 - 10:38 am

idiopathic pulmonary fibrosis

InterMune's Esbriet rings up $2.8 million in sales since mid-September launch in Germany

Yahoo/AP

Thu, 01/5/12 - 01:01 pm

idiopathic pulmonary fibrosis

ITMN's Esbriet Safe Long Term

Yahoo/Zacks

Sat, 10/1/11 - 12:45 pm

idiopathic pulmonary fibrosis

InterMune is Latest Biotech to Test Investors' Stomach for a Drug Launch

Minyanville

Mon, 09/12/11 - 01:25 pm

InterMune Surges on EC Drug Approval

Barron's

Thu, 03/3/11 - 05:57 pm

5 Drugmakers Headed Back to the Drawing Board

Motley Fool

Mon, 01/31/11 - 06:54 pm

Arena Pharmaceuticals

InterMune to start new IPF drug trial

Bizjournals

Mon, 01/10/11 - 12:37 pm

InterMune surges on EU lung drug recommendation

Yahoo/AP

Sat, 12/18/10 - 12:18 pm

idiopathic pulmonary fibrosis

Seven Biotech Drugs to Watch in the Second Quarter

BNET Pharma

Tue, 04/13/10 - 10:35 am

Acorda Therapeutics

Cell Therapeutics

OSI Pharmaceuticals

Pages